Circulating endothelial cells in health and disease: How do we best quantify them?

Journal of Thrombosis and Haemostasis

Volumn 6, Issue 6, 2008, Pages 1021-1024

  Shantsila, E ^a   Lip, G Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; CYTOKINE;

APOPTOSIS; BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL ACTIVATION; CELL ADHESION; CELL COUNT; CELL DEATH; CELL DENSITY; CELL FUNCTION; CELL STRUCTURE; CELL VIABILITY; CIRCULATION; CYTOLOGY; CYTOLYSIS; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL MICROPARTICLE; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; IMMUNOMAGNETIC SEPARATION; INTERMETHOD COMPARISON; MONONUCLEAR CELL; NOTE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STEM CELL; T LYMPHOCYTE; VASCULAR ENDOTHELIUM;

ANTIGENS, CD146; BLOOD CIRCULATION; CARDIOVASCULAR DISEASES; CELL SEPARATION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOMAGNETIC SEPARATION; MODELS, BIOLOGICAL; RISK; STRESS, MECHANICAL;

EID: 43749117732     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2008.02985.x     Document Type: Note

References (32)

1. Widlansky ME, Gokce N, Keaney JF Jr, Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol 2003; 42: 1149-60.
2. Thogersen AM, Jansson J, Boman K, Nilsson TK, Weinehall L. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: Evidence for the fibrinolytic system as an independent primary risk factor. Circulation 1998; 98: 2241-7.
3. Cushman M, Lemaitre RN, Kuller LH, Psaty BM, Macy EM, Sharrett AR, Tracy RP. Fibrinolytic activation markers predict myocardial infarction in the elderly: The Cardiovascular Health study. Arterioscler Thromb Vasc Biol 1999; 19: 493-8.
4. Ruiz-Ortega M, Lorenzo O, Rupérez M, Esteban V, Suzuki Y, Mezzano S, Plaza JJ, Egido J. Role of the reninangiotensin system in vascular diseases: Expanding the field. Hypertension 2001; 38: 1382-7.
5. Boos CJ, Lip GY, Blann AD. Circulating endothelial cells in cardiovascular disease. J Am Coll Cardiol 2006; 48: 1538-47.
6. Hasmim M, Vassalli G, Alghisi GC, Bamat J, Ponsonnet L, Bieler G, Bonnard C, Paroz C, Oguey D, Rüegg C. Expressed isolated integrin beta1 subunit cytodomain induces endothelial cell death secondary to detachment. Thromb Haemost 2005; 94: 1060-70.
7. Ballieux BE, Hiemstra PS, Klar-Mohamad N, Hagen EC, van Es LA, van der Woude FJ, Daha MR. Detachment and cytolysis of human endothelial cells by proteinase 3. Eur J Immunol 1994; 24: 3211-5.
8. Boehme MW, Galle P, Stremmel W. Kinetics of thrombomodulin release and endothelial cell injury by neutrophil-derived proteases and oxygen radicals. Immunology 2002; 107: 340-9.
9. Boos CJ, Lane DA, Karpha M, Beevers DG, Haynes R, Lip GY. Circulating endothelial cells, arterial stiffness, and cardiovascular risk stratification in hypertension. Chest 2007; 132: 1540-7.
10. Bull TM, Golpon H, Hebbel RP, Solovey A, Cool CD, Tuder RM, Geraci MW, Voelkel NF. Circulating endothelial cells in pulmonary hypertension. Thromb Haemost 2003; 90: 698-703.
11. Lee KW, Lip GY, Tayebjee M, Foster W, Blann AD. Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes. Blood 2005; 105: 526-32.
12. George F, Brouqui P, Boffa MC, Mutin M, Drancourt M, Brisson C, Raoult D, Sampol J. Demonstration of Rickettsia conorrii-induced endothelial injury in vivo by measuring circulating endothelial cells, thrombomodulin and von Willebrand factor in patients with Meditteranean spotted fever. Blood 1993; 82: 2109-16.
13. Woywodt A, Streiber F, de Groot K, Regelsberger H, Haller H, Haubitz M. Circulating endothelial cells as markers for ANCA-associated small vessel vasculitis. Lancet 2003; 361: 206-10.
14. Woywodt A, Bahlmann FH, de Groot K, Haller H, Haubitz M. Circulating endothelial cells: Life, death and detachment of the endothelial cell layer. Nephrol Dial Transplant 2002; 17: 1728-30.
15. Dignat-George F, Sampol J. Circulating endothelial cells in vascular disorders: New insights into an old concept. Eur J Haematol 2000; 65: 215-20.
16. Solovey A, Gui L, Ramakrishnan S, Steinberg MH, Hebbel RP. Sickle cell anemia as a possible state of enhanced anti-apoptotic tone: Survival effect of vascular endothelial growth factor on circulating and unanchored endothelial cells. Blood 1999; 93: 3824-30.
17. Solovey A, Gui L, Key NS, Hebbel RP. Tissue factor expression by endothelial cells in sickle cell anemia. J Clin Invest 1998; 101: 1899-904.
18. Kas-Deelen AM, Harmsen MC, de Maar EF, Oost-Kort WW, Tervaert JW, van der Meer J, van Son WJ, The TH. Acute rejection before cytomegalovirus infection enhances von Willebrand factor and soluble VCAM-1 in blood. Kidney Int 2000; 58: 2533-42.
19. Woywodt A, Blann AD, Kirsch T, Erdbruegger U, Banzet N, Haubitz M, Dignat-George F. Isolation and enumeration of circulating endothelial cells by immunomagnetic isolation: Proposal of a definition and a consensus protocol. J Thromb Haemost 2006; 4: 671-7.
20. Elshal MF, Khan SS, Takahashi Y, Solomon MA, McCoy JP Jr. CD146 (Mel-CAM), an adhesion marker of endothelial cells, is a novel marker of lymphocyte subset activation in normal peripheral blood. Blood 2005; 106: 2923-4.
21. Blann AD, Woywodt A, Bertolini F, Bull TM, Buyon JP, Clancy RM, Haubitz M, Hebbel RP, Lip GY, Mancuso P, Sampol J, Solovey A, Dignat-George F. Circulating endothelial cells. Biomarker of vascular disease. Thromb Haemost 2005; 93: 228-35.
22. Khan SS, Solomon MA, McCoy JP Jr. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry B Clin Cytom 2005; 64: 1-8.
23. Rafii S. Circulating endothelial precursors: Mystery, reality, and promise. J Clin Invest 2000; 105: 17-9.
24. Widemann A, Sabatier F, Arnaud L, Bonello L, Massarani G, Paganelli F, Poncelet P, Dignat-George F. CD146-based immunomagnetic enrichment followed by multi-parameter flow cytometry: A new approach to count circulating endothelial cells. J Thromb Haemost 2008; 6: 869-70.
25. George F, Poncelet P, Laurent JC, Massot O, Arnoux D, Lequeux N, Ambrosi P, Chicheportiche C, Sampol J. Cytofluorometric detection of human endothelial cells in whole blood using S-Endo 1 monoclonal antibody. J Immunol Methods 1991; 139: 65-75.
26. Goon PK, Boos CJ, Stonelake PS, Blann AD, Lip GY. Detection and quantification of mature circulating endothelial cells using flow cytometry and immunomagnetic beads: A methodological comparison. Thromb Haemost 2006; 96: 45-52.
27. Clarke LA, Shah V, Arrigoni F, Eleftheriou D, Hong Y, Halcox J, Klein N, Brogan PA. Quantitative detection of circulating endothelial cells in vasculitis: Comparison of flow cytometry and immunomagnetic bead extraction. J Thromb Haemost 2008; 6: 1025-32.
28. Darzynkiewicz Z, Juan G, Li X, Gorczyca W, Murakami T, Traganos F. Cytometry in cell necrobiology: Analysis of apoptosis and accidental cell death (necrosis). Cytometry 1997; 27: 1-20.
29. Shaffer RG, Greene S, Arshi A, Supple G, Bantly A, Moore JS, Mohler ER III. Flow cytometric measurement of circulating endothelial cells: The effect of age and peripheral arterial disease on baseline levels of mature and progenitor populations. Cytometry B Clin Cytom 2006; 70: 56-62.
30. Fürstenberger G, von Moos R, Lucas R, Thürlimann B, Senn HJ, Hamacher J, Boneberg EM. Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer. Br J Cancer 2006; 94: 524-31.
31. Jaroszeski MJ, Radcliff G. Fundamentals of flow cytometry. Mol Biotechnol 1999; 11: 37-53.
32. Beerepoot LV, Mehra N, Vermaat JS, Zonnenberg BA, Gebbink MF, Voest EE. Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients. Ann Oncol 2004; 15: 139-45.